SEARCH

PTAB.US: Decisions of PTAB Patent Trial and Appeal Board Updated Daily.

Tuesday, August 24, 2010

Tuesday August 24, 2010

REVERSED

1600 Biotechnology and Organic Chemistry
Ex Parte Kapur et al 10/934,893 ADAMS 112(1) FISH & RICHARDSON P.C.
Examiner Name: SWARTZ, RODNEY P


Ex Parte MacDonald et al 10/686,933 WALSH 103(a) DORITY & MANNING, P.A.
Examiner Name: HARTLEY, MICHAEL G

“It is impermissible to use the claimed invention as an instruction manual or ‘template’ to piece together the teachings of the prior art so that the claimed invention is rendered obvious….” See In re Fritch, 972 F.2d 1260, 1266 (Fed. Cir. 1992).

Fritsch v. Lin, 21 USPQ2d 1731 (Bd. Pat. App. & Inter. 1991) . . . .2137.01, 2138.06

Ex Parte Ramesh et al 10/453,912 McCOLLUM 103(a) NUTTER MCCLENNEN & FISH LLP
Examiner Name: CHONG, YONG SOO


Ex Parte Spruce et al 10/473,295 ADAMS 103(a) MYERS BIGEL SIBLEY & SAJOVEC
Examiner Name: SANG, HONG


1700 Chemical & Materials Engineering
Ex Parte Wash 11/179,376 PAK 103(a) PRICE HENEVELD COOPER DEWITT & LITTON, LLP
Examiner Name: KIM, SUN U


Ex Parte Yan et al 10/407,609 GAUDETTE 103(a) HARNESS, DICKEY & PIERCE, P.L.C.
Examiner Name: MERCADO, JULIAN A


In In re Crish, our reviewing court interpreted the phrase “consists of,” appearing in the body of a claim, as limiting the clause for which it acts as a transition to only those elements found in that particular clause. 393 F.3d 1253, 1257 (Fed. Cir. 2004) (“The reasonable interpretation of … claims containing both of the terms ‘comprising’ and ‘consists' is that the term ‘consists' limits the ‘said portion’ language to the subsequently recited numbered nucleotides, but the earlier term ‘comprising’ means that the claim can include that portion plus other nucleotides.”). Although “comprising” is not as restrictive as “consisting of,” it is, nonetheless, “a term of art . . . mean[ing] that the named elements are essential, but other elements may be added and still form a construct within the scope of the claim,” Genentech, Inc. v. Chiron Corp., 112 F.3d 495, 501 (Fed. Cir. 1997).

Crish, In re, 393 F.3d 1253, 73 USPQ2d1364 (Fed. Cir. 2004) . . . . . . . . . . . . .2111.03, 2112

Genentech, Inc. v. Chiron Corp., 112 F.3d495, 42 USPQ2d 1608 (Fed. Cir. 1997) . . . 2111.03,2138.05, 2163

Ex Parte Barbee et al 10/261,879 WARREN 103(a) ANN M. LEE LAWRENCE LIVERMORE NATIONAL LABORATORY
Examiner Name: FELTON, AILEEN BAKER

2100 Computer Architecture and Software
Ex Parte Ito 10/863,777 THOMAS 103(a) NIXON & VANDERHYE, PC
Examiner Name: KIM, HONG CHONG

2400 Networking, Mulitplexing, Cable, and Security
Ex Parte Dureau 10/271,801 HAIRSTON 101/102(e)/103(a) OPTV/MEYERTONS MEYERTONS, HOOD, KIVLIN, KOWERT & GOETZEL, P.C.
Examiner Name: HUYNH, SON P

2600 Communications
Ex Parte Ng et al 10/561,194 MANTIS MERCADER 103(a) Dickinson Wright PLLCJames E. Ledbetter, Esq.
Examiner Name: CHAMBERS, TANGELA T


Ex Parte Hirakawa et al 10/811,246 SAADAT 103(a) RADER FISHMAN & GRAUER PLLC
Examiner Name: LEIBY, CHRISTOPHER E

3700 Mechanical Engineering, Manufacturing, and Products & Design

Ex Parte Maeda et al 11/274,170 KERINS 103(a) SUGHRUE-265550
Examiner Name: NGUYEN, DUNG V

AFFIRMED-IN-PART

1600 Biotechnology and Organic Chemistry
Ex Parte Meyer 10/521,599 PRATS 112(2)/103(a)/obviousness type double patenting RANKIN, HILL & CLARK LLP
Examiner Name: ARNOLD, ERNST V

2400 Networking, Mulitplexing, Cable, and Security
Ex Parte Tsuji et al 10/154,129 HAHN 103(a) HUNTON & WILLIAMS, L.L.P.
Examiner Name: JOO, JOSHUA

2800 Semiconductors, Electrical and Optical Systems and Components
Ex Parte Westphall et al 11/199,845 HAIRSTON 102(a)/103(a) HEWLETT PACKARD COMPANY
Examiner Name: DESAI, NIDHI


3700 Mechanical Engineering, Manufacturing, and Products & Design
Ex parte CATERPILLAR INC. 10/952,887 LEE 103(a) CATERPILLAR/FINNEGAN, HENDERSON, L.L.P.
Examiner Name: TRIEU, THAI BA

Ex Parte Khan et al 10/812,380 McCARTHY 103(a) NAZIR A. KHAN, MD
Examiner Name: DEAK, LESLIE R

VACATED

1600 Biotechnology and Organic Chemistry
Ex Parte Buechler et al 10/193,960 GREEN 103(a)/102(b) 37 C.F.R. § 41.50(b) INVERNESS MEDICAL INNOVATIONS / WSGR WILSON SONSINI GOODRICH & ROSATI, P.C.
Examiner Name: WESSENDORF, TERESA D


NEW

REVERSED

Ex Parte Barry et al
Ex Parte Goela et al
Ex Parte Horak
Ex Parte Lyon et al
Ex Parte Meltzer et al
Ex Parte Menrad et al
Ex Parte O’HARA et al

AFFIRMED-IN-PART

Ex Parte Gilinsky
Ex Parte Tanaka

VACATED

Ex Parte Christian et al

AFFIRMED

Ex Parte Adachi et al
Ex Parte Agapi et al
Ex Parte Bergeron
Ex Parte Bouquet et al
Ex Parte Classen
Ex Parte Cooper et al
Ex Parte Dunifon et al
Ex Parte Fogarty et al
Ex Parte Lyu et al
Ex Parte Magnuson et al
Ex Parte Manning
Ex Parte Obrea et al
Ex Parte Rastegar et al
Ex Parte Semersky et al
Ex Parte Stromblad et al
Ex Parte Wegehaupt
Ex Parte Zhang et al

REHEARING

Ex Parte Batra et al
Ex Parte Demarcken et al

No comments :